SULLIVAN CHRISTOPHER RYAN (Interim CFO) reported 1 transaction at AVALO THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/12/2026ACC: 0001810417-26-000016
Officer· Interim CFO
Since Apr 2020
-138.00
Net shares
Net seller
$1.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
138.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−138.00
Price / share
$13.10
Trade value
$1.81K
% of position
0.3%
6/10/2026
40.91K→40.77K
Total
Net shares
−138.00
Net value
-$1.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2026 | F · Tax Withholding | −138.00 | $13.10 | $1.81K | 0.3% | 40.91K | 40.77K |
| Total | −138.00 | -$1.81K | ||||||
Derivative Transactions0
No derivative transactions reported